Promising malaria vaccine trial aims to break the cycle of infection
Prevention
Recruiting now
This study tests a new two-part malaria vaccine in 1,200 healthy people aged 9 to 50 in Mali. The goal is to see if the vaccine is safe and can prevent both malaria illness and transmission from person to mosquito. Participants will receive either the vaccine or a control, and re…
Phase: PHASE2 • Sponsor: Serum Institute of India Pvt. Ltd. • Aim: Prevention
Last updated Apr 26, 2026 19:39 UTC